Siu-Lung Chan (Kelvin)

Siu-Lung (Kelvin) Chan is a Senior Scientist at Enanta Pharmaceuticals since May 2022, where significant contributions include investigating pharmacokinetic profiles of antiviral compounds for COVID-19 and respiratory syncytial virus treatments. In addition to this role, Chan serves as a Scientific Writing Consultant for Accdon, LLC and previously for Creaducate Consulting GmbH, specializing in editing and translating scientific manuscripts. Previous experience includes a Staff Scientist position at Harvard Medical School, where collaboration with Innolign Biomedical led to advancements in lymphedema treatment, and extensive research roles at the University of Vermont and The University of Iowa. Educational qualifications include a PhD in Pharmacology and a BS in Biology from The Chinese University of Hong Kong, with ongoing studies for a Graduate Certificate in Biotechnology Management at Harvard Extension School.